ChemPartner

ChemPartner is a leading research organization providing high-quality and cost-effective CRO/CMO services to the pharmaceutical and biotechnology industry.

[ChemPartner @ChemPartner]

✨Thank you for joining us this week at #DDC2026 in San Diego! Missed us at the show and want to explore @ChemPartner's latest innovations and solutions in drug discovery chemistry?✨

𝗟𝗲𝘁𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁👉https://t.co/aAOz7onV1v

[ChemPartner @ChemPartner]

🎉Explore @ChemPartner's latest #oncology posters in San Diego at #AACR2026!

𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲👉

https://t.co/kVKhX9QNPv

#BioPharma #CancerResearch

[ChemPartner @ChemPartner]

🎉@ChemPartner officially opened its first UK scientific hub – and we’re proud of what this milestone represents.

Last week, our Global Leadership team joined the UK team at Discovery Park, in Sandwich, to celebrate this significant milestone!📸

[ChemPartner @ChemPartner]

Attending #AACR2026 next week in San Diego? Visit our @ChemPartner experts in booth 4415 to discuss your #oncology programs! #CancerResearch

[ChemPartner @ChemPartner]

𝗪𝗲 𝗮𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘀𝗵𝗮𝗿𝗲 𝘁𝗵𝗮𝘁 𝗼𝘂𝗿 𝗮𝗯𝘀𝘁𝗿𝗮𝗰𝘁 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝘀𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗳𝗼𝗿 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 #𝗔𝗔𝗖𝗥𝟮𝟬𝟮𝟲!

“Modeling of Acquired Resistance to the Multi-RAS Inhibitor RMC6236 in KRAS Mutant Pancreatic Ductal Adenocarcinoma”

[ChemPartner @ChemPartner]

𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗳𝗿𝗼𝗺 @𝗖𝗵𝗲𝗺𝗣𝗮𝗿𝘁𝗻𝗲𝗿 – 𝗪𝗲’𝗿𝗲 𝗘𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗞!

𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗣𝗿𝗲𝘀𝘀 𝗥𝗲𝗹𝗲𝗮𝘀𝗲:

https://t.co/Mf5GeejPTk

#BioPharma #BioTech

[ChemPartner @ChemPartner]

🚨𝗥𝗲𝗺𝗶𝗻𝗱𝗲𝗿: Interested in #CancerResearch? Join @ChemPartner Next Tuesday for a @GENbio Webinar on Next-Generation #ADCs!

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄👉

https://t.co/YpjCFZsrsu

[ChemPartner @ChemPartner]

Join Us Next Month at #AACR2026 in San Diego!

Stop by booth 4415 to meet our team and start a conversation around your oncology programs. With over 20 years of experience partnering with innovators, @ChemPartner provides high-quality, decision-enabling data.

#CancerResearch

[ChemPartner @ChemPartner]

🎉It's day 3 at #SOT2026 in San Diego! There's still time to stop by 𝗯𝗼𝗼𝘁𝗵 𝟭𝟬𝟰𝟴 and meet our experts, to discuss how @ChemPartner's global platform and regulatory expertise can help de-risk your #toxicology strategy.

#ToxExpo #Pharmacology

[ChemPartner @ChemPartner]

🎉There's still time to meet our experts, Dami Filani and Bing Li, in Booth 617 at the 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 (𝗔𝗖𝗦) 𝗦𝗽𝗿𝗶𝗻𝗴 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 for a conversation on @ChemPartner's latest chemistry services and innovations.

#ACS150 #BioPharma

[ChemPartner @ChemPartner]

🎉It's day 1 at #SOT2026 in San Diego! Join @ChemPartner in booth 1048 to see how we help drug developers advance safer, more efficient programs with confidence!

Learn more👉

https://t.co/9nkrMqyN0b

[ChemPartner @ChemPartner]

It's day 1 at 𝗔𝗖𝗦 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟲, now celebrating its 150th year in Atlanta!

While at the #ACS150, meet our experts this week in Booth 617 for a conversation on @ChemPartner's latest chemistry services and innovations.

𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲:

https://t.co/CgYgT9A7ZM

[ChemPartner @ChemPartner]

🚀 Exciting News from @ChemPartner – We’re Expanding in the UK!

We’re proud to announce the opening of our 𝗻𝗲𝘄 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝘀𝗶𝘁𝗲 𝗮𝘁 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗣𝗮𝗿𝗸 𝗶𝗻 𝗦𝗮𝗻𝗱𝘄𝗶𝗰𝗵, one of the UK’s leading science and innovation hubs, just an hour from London!

[ChemPartner @ChemPartner]

Join @ChemPartner this month at one of the year’s biggest events in science, 𝗔𝗖𝗦 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟲, now celebrating its 150th year, in Atlanta, GA! #ACS150

𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲👉

https://t.co/tDtX83eTJB

[ChemPartner @ChemPartner]

Interested in strategies for overcoming resistance and off-target toxicity in next-generation #ADC's? Attend @ChemPartner's 𝗚𝗘𝗡 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝗔𝗗𝗖'𝘀 later this month!

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄👉

https://t.co/y2JrUZiPJ7

#BioPharma #Oncology #CRO

[ChemPartner @ChemPartner]

#𝗪𝗼𝗿𝗹𝗱𝗔𝗗𝗖𝗟𝗼𝗻𝗱𝗼𝗻 𝗵𝗮𝘀 𝘄𝗿𝗮𝗽𝗽𝗲𝗱

It was great diving into thoughtful conversations about where #ADC science is heading next. Let’s keep the discussions going!

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗼𝘂𝗿 𝗽𝗼𝘀𝘁𝗲𝗿👉

https://t.co/1PrvF8piZM

[ChemPartner @ChemPartner]

We're heading to #𝗪𝗼𝗿𝗹𝗱𝗔𝗗𝗖𝗟𝗼𝗻𝗱𝗼𝗻 𝟮𝟬𝟮𝟲 next week to talk about what's next in #ADC innovation. Stop by Booth 35 for a conversation on how diverse modality ADC design is pushing the boundaries of therapeutic efficacy. #CRO

[ChemPartner @ChemPartner]

💡40-70% of new molecules flag hERG liability → many promising compounds dropped early due to false alarms in traditional assays.

🚨At @ChemPartner, we deliver validated CiPA to spot true risks early, align w/ ICH E14/S7B & build stronger INDs.

[ChemPartner @ChemPartner]

@ChemPartner's updated visual identity comes with a faster, smarter https://t.co/QKocDAksHA.

🚀Built for scientists: instant clarity, intuitive navigation across the discovery pipeline, and direct access to experts worldwide.

Catalytic innovation - on your terms.

#BioPharma

[ChemPartner @ChemPartner]

Tumor heterogeneity is why ADCs fail: You have perfect payload, optimized linker, clear MoA.

❌And the tumor adapts! Dual-payload ADCs (dpADCs) widen cytotoxic coverage-but require perfect DAR optimization.

👉Read more on our blog: https://t.co/ovZBgcPHK0

#ADC #Oncology #DAR